Luteolin for ALS

Also known as: 3',4',5,7-Tetrahydroxyflavone

Luteolin's mast cell stabilization and anti-inflammatory effects may reduce non-cell-autonomous motor neuron toxicity.

Mechanism of Action

Luteolin stabilizes brain mast cells, suppresses microglial activation through NF-κB/JNK inhibition, and reduces pro-inflammatory cytokines damaging motor neurons. Its BBB penetrance enables CNS anti-inflammatory effects.

General mechanism: Flavone. Mast cell stabilizer, NF-κB/NLRP3 inhibitor, CK2 inhibitor, BACE1 inhibitor, Nrf2 activator. Crosses BBB.

Current Evidence

Preclinical neuroprotection data. Mast cell involvement in ALS is an emerging area. No ALS trials.

Clinical Status: Preclinical. MCI pilot trial informs dosing.

Safety Profile

Very safe. Present in celery, peppers, parsley. Well-tolerated as supplement. No significant side effects.

Key Research Questions

View glossary entry →

← Back to ALS Research